Steven Wang, MD
MOHS-Micrographic Surgery · Basking Ridge, NJNPI 1265511968
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by LEO Pharma AS at 52.0% of the total.
Across 50 payments — averaging $217.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma AS$6K
- Regeneron Healthcare Solutions, Inc.$4K
- Incyte Corporation$205
- E.r. Squibb & Sons, L.L.C.$191
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$178
- Merck$137
- plus $868 from 16 others
Across 1 payment — averaging $5255.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$5K
What the payments were for
- Consulting fees$5,64052%
- Speaking & faculty fees$3,38431%
- Food & beverage$1,82917%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma AS | 1 | $5,640 |
| Regeneron Healthcare Solutions, Inc. | 7 | $3,633 |
| Incyte Corporation | 4 | $205 |
| E.r. Squibb & Sons, L.L.C. | 6 | $191 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $178 |
| Merck | 5 | $137 |
| AbbVie | 1 | $117 |
| Immunocore Limited | 1 | $116 |
| Bristol Myers Squibb | 1 | $116 |
| Biofrontera Inc. | 6 | $116 |
| Sanofi-aventis U.S. LLC | 1 | $91 |
| Foundation Medicine, Inc. | 2 | $64 |
| Heartflow, Inc. | 3 | $51 |
| Baxter Healthcare | 1 | $37 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Puma Biotechnology, Inc. | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $22 |
| Boston Scientific | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Seagen Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Orthogenrx Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,853 in reported general payments places this provider in the 85th percentile of 30 mohs-micrographic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 143 | $8,534 |
| Mupirocin | 210 | $1,344 |
| Imiquimod | 21 | $616 |
| Fluocinonide | 14 | $471 |
| Ketoconazole | 17 | $292 |
| Triamcinolone Acetonide | 29 | $196 |
| Cephalexin | 27 | $140 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Basking Ridge
- David GoldbergHackensack$820K
- Marc GlashoferWest Orange$175K
- Kehua LiSewell$22K
- John VinePrinceton$8K
- Lian Jie LiPhillipsburg$7K
- David NajarianRandolph$5K
- Parth PatelBridgewater$4K
- Shreya PatelWest Orange$3K
- Jeffrey WhitworthWoodland Park$3K
- Otter AspenRockaway$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.